Palacios Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$374K Buy
6,167
+96
+2% +$5.6K 0.23% 55
2025
Q4
$327K Sell
6,071
-2,230
-27% -$107K 0.25% 50
2025
Q3
$374K Buy
8,301
+50
+0.6% +$2.33K 0.25% 52
2025
Q2
$382K Buy
8,251
+435
+6% +$21.4K 0.31% 46
2025
Q1
$477K Hold
7,816
0.35% 38
2024
Q4
$440K Buy
+7,816
New +$437K 0.48% 40

Other funds holding BMY

Palacios Wealth Management's BMY Position: Q1 2026 in Review

Palacios Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2026, buying an estimated $5.6K and bringing the position to 6,167 shares worth $374K. The position accounts for 0.23% of the portfolio, ranked #55.

Palacios Wealth Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $477K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Palacios Wealth Management held 6,167 shares of Bristol-Myers Squibb worth $374K as of Q1 2026.
  • Palacios Wealth Management bought 96 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.6K.
  • Bristol-Myers Squibb made up 0.23% of Palacios Wealth Management's portfolio in Q1 2026, its #55 holding.
  • Palacios Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Palacios Wealth Management's Bristol-Myers Squibb position peaked at $477K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Palacios Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.